Proteostasis Therapeutics Announces Positive Phase 2 Topline Results from Proprietary CFTR Modulator Combinations in F508del Homozygous Cystic Fibrosis Patients

Stock Information for Proteostasis Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.